Skip to content
Menu

BioNexus Gene Lab Corp. BGLC

Full chart Compare
Set alert

Price alert · BGLC

All alert types
0.68 USD -0.05 (-7.29%)

Regular-session close

0.68 0.00 0.00%

After hours · Nov 19, 4:00 PM ET

0.6586 Day range 0.753
0.6586 52-week range 4.97
YTD
-82.78%
1 year
-85.80%

BGLC revenue history

Revenue is income from the company’s ordinary business activities.

7,424,911 USD

FY 2025 · Period ended

Coverage: complete. Values in USD; not inflation adjusted.

Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.

Scroll the table to see all values →

Revenue · annual · USD
Fiscal periodPeriod endRevenueYoY changeYoY %
FY 20252025-12-317,424,911-2,085,735-21.93%
FY 20242024-12-319,510,646-260,160-2.66%
FY 20232023-12-319,770,806-1,157,901-10.60%
FY 20222022-12-3110,928,707-2,433,860-18.21%
FY 20212021-12-3113,362,5671,972,12717.31%
FY 20202020-12-3111,390,44011,263,4858872.03%
FY 20192019-12-31126,955-85,373-40.21%
FY 20182018-12-31212,328104,64897.18%
FY 20172017-12-31107,680Not availableNot available

Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.

Company-reported financial statements. Retrieved 2026-05-22T14:43:38.000Z. Retrieval time is not a report date.

Open full statements

Use Add to watchlist above to save this stock.